Meta-level question: how do you evaluate evidence for liraglutide when the human data is thin and most trials are small? Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
A plausible mechanism is not an outcome, and this class is the textbook example.
Loose evidence and no evidence are different, and people overcorrect in both directions.
Most of what is called evidence here is one person, one vial, one month. A fortnight in on liraglutide and it lines up.
How long before you can reasonably say something is or is not doing anything?
Is a baseline blood test really necessary before starting something like this?
A certificate of analysis answers one question and gets quoted as though it answers four. Currently on liraglutide myself.
Most of the popular protocol is borrowed from a clinical population and applied to healthy people without comment.
Narrow conclusion.
What is the first thing you would read if you were starting from zero?
Sleep, food, or the compound? Yes.
Sleep, food, or the compound? Yes.
Nobody has ever been talked out of a stack by a stranger on the internet.
This board overrates bloodwork. A number moving is not the outcome you wanted.
Baseline first.